Multidrug resistance: can new drugs help chemotherapy score against cancer?

J Natl Cancer Inst. 2003 Feb 19;95(4):255-7. doi: 10.1093/jnci/95.4.255.
No abstract available

Publication types

  • News

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / antagonists & inhibitors
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism*
  • Animals
  • Antineoplastic Agents / pharmacology*
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Clinical Trials, Phase III as Topic
  • Cyclosporins / pharmacology
  • Dibenzocycloheptenes / pharmacology
  • Drug Resistance, Multiple*
  • Drug Resistance, Neoplasm*
  • Drugs, Investigational / pharmacology
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy
  • Lung Neoplasms / drug therapy
  • Membrane Transport Proteins*
  • Multidrug Resistance-Associated Protein 2
  • Multidrug Resistance-Associated Proteins / drug effects
  • Multidrug Resistance-Associated Proteins / metabolism*
  • National Institutes of Health (U.S.)
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Piperidines / pharmacology
  • Pyridines / pharmacology
  • Quinolines / pharmacology
  • United States

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Antineoplastic Agents
  • Cyclosporins
  • Dibenzocycloheptenes
  • Drugs, Investigational
  • Membrane Transport Proteins
  • Multidrug Resistance-Associated Protein 2
  • Multidrug Resistance-Associated Proteins
  • Piperidines
  • Pyridines
  • Quinolines
  • biricodar
  • zosuquidar trihydrochloride
  • valspodar
  • multidrug resistance-associated protein 1